| Product Code: ETC10131323 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia mRNA Vaccine and Therapeutics Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Zambia mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Zambia mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for healthcare infrastructure and research and development in Zambia |
4.2.2 Rising awareness and adoption of mRNA vaccines and therapeutics for various diseases in the country |
4.2.3 Growing partnerships and collaborations between local and international pharmaceutical companies to develop and distribute mRNA vaccines and therapeutics in Zambia |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Zambia, impacting the distribution and administration of mRNA vaccines and therapeutics |
4.3.2 High costs associated with mRNA vaccine development and production, potentially limiting accessibility in the market |
5 Zambia mRNA Vaccine and Therapeutics Market Trends |
6 Zambia mRNA Vaccine and Therapeutics Market, By Types |
6.1 Zambia mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Zambia mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Zambia mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Zambia mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Zambia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Zambia mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Zambia mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Zambia mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Zambia mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for mRNA vaccines and therapeutics in Zambia |
8.2 Percentage increase in healthcare professionals trained in administering mRNA vaccines |
8.3 Adoption rate of mRNA vaccines and therapeutics among the target population in Zambia |
9 Zambia mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Zambia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Zambia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Zambia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Zambia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Zambia mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Zambia mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Zambia mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |